United States · FDA National Drug Code directory

Suprane

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
10019-644_ec545337-e75b-46c5-981a-f49cea274749
Product NDC
10019-644
Form
LIQUID
Composition / generic term
DESFLURANE
Labeler
Baxter Healthcare Corporation
Marketing category
NDA
Marketing start / end (source format)
19920918
Source listing expiry
20271231

Source-listed ingredients

  • DESFLURANE — 240 mL/240mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 6 BOTTLE in 1 CARTON (10019-644-34) / 240 mL in 1 BOTTLE (10019-644-64) · 10019-644-34

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Suprane — United States | Molindra Medicines